Cargando…

Radioimmunotherapy of pancreatic cancer xenografts in nude mice using (90)Y-labeled anti-α(6)β(4) integrin antibody

The contribution of integrin α(6)β(4) (α(6)β(4)) overexpression to the pancreatic cancer invasion and metastasis has been previously shown. We have reported immunotargeting of α(6)β(4) for radionuclide-based and near-infrared fluorescence imaging in a pancreatic cancer model. In this study, we prepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aung, Winn, Tsuji, Atsushi B., Sudo, Hitomi, Sugyo, Aya, Ukai, Yoshinori, Kouda, Katsushi, Kurosawa, Yoshikazu, Furukawa, Takako, Saga, Tsuneo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122433/ https://www.ncbi.nlm.nih.gov/pubmed/27246980 http://dx.doi.org/10.18632/oncotarget.9631

Ejemplares similares

Combined treatment of pancreatic cancer xenograft with (90)Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor
por: Aung, Winn, et al.
Publicado: (2017)

Immunotargeting of Integrin α(6)β(4) for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model
por: Aung, Winn, et al.
Publicado: (2016)

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2018)

Evaluation of Efficacy of Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models
por: Sugyo, Aya, et al.
Publicado: (2015)

Therapeutic efficacy evaluation of radioimmunotherapy with (90)Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2019)

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
por: Yoshida, Chisato, et al.
Publicado: (2013)

Evaluation of (89)Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2013)

Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression
por: Sudo, Hitomi, et al.
Publicado: (2020)

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2021)

FZD10‐targeted α‐radioimmunotherapy with (225)Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model
por: Sudo, Hitomi, et al.
Publicado: (2021)

The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
por: Takakusagi, Yoichi, et al.
Publicado: (2021)

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
por: Antoniw, P., et al.
Publicado: (1996)

Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996)

Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role
por: Yuan, Qinghua, et al.
Publicado: (2015)

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with (64)Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts
por: Yoshii, Yukie, et al.
Publicado: (2018)

Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake
por: Sugyo, Aya, et al.
Publicado: (2020)

(64)Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts
por: Yoshii, Yukie, et al.
Publicado: (2017)

Radioimmunotherapy for Liver Micrometastases in Mice: Pharmacokinetics, Dose Estimation, and Long‐term Effect
por: Saga, Tsuneo, et al.
Publicado: (1999)

Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice
por: Weng, Dinghu, et al.
Publicado: (2017)

Quantitative Radionuclide Imaging Analysis of Enhanced Drug Delivery Induced by Photoimmunotherapy
por: Aung, Winn, et al.
Publicado: (2021)

Avidin Chase Can Reduce Myelotoxicity Associated with Radioimmunotherapy of Experimental Liver Micrometastases in Mice
por: Sato, Noriko, et al.
Publicado: (2000)

Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody
por: Aung, Winn, et al.
Publicado: (2018)

Intraperitoneal Alpha-Radioimmunotherapy of Advanced Ovarian Cancer in Nude Mice Using Different High Specific Activities
por: Elgqvist, Jorgen, et al.
Publicado: (2010)

In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized (64)Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study
por: Hihara, Fukiko, et al.
Publicado: (2022)

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991)

Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
por: Turner, J. H., et al.
Publicado: (1998)

Enhanced Efficacy of Radioimmunotherapy Combined with Systemic Chemotherapy and Local Hyperthermia in Xenograft Model
por: Kinuya, Seigo, et al.
Publicado: (2000)

Comparative Efficacy of (177)Lu and (90)Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models
por: Frost, Sofia H. L., et al.
Publicado: (2015)

Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma
por: Ludwig, Andrew D., et al.
Publicado: (2019)

In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([(189, 191)Pt]cisplatin) Emitting Auger Electrons
por: Obata, Honoka, et al.
Publicado: (2021)

Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice
por: Obata, Honoka, et al.
Publicado: (2022)

Reliable Establishment of Human Sarcoma Xenografts in the Nude Rat
por: Tinkey, Peggy T., et al.
Publicado: (1999)

The development of xenograft glioblastoma implants in nude mice brain
por: Behar, FM, et al.
Publicado: (2008)

Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent (211)At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice
por: Sudo, Hitomi, et al.
Publicado: (2019)

Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
por: Lin, Ruoting, et al.
Publicado: (2021)

MMP-9, uPAR and Cathepsin B Silencing Downregulate Integrins in Human Glioma Xenograft Cells In Vitro and In Vivo in Nude Mice
por: Veeravalli, Krishna Kumar, et al.
Publicado: (2010)

Growth of human digestive-tumour xenografts in athymic nude rats.
por: Davies, G., et al.
Publicado: (1981)

BCG treatment of human tumour xenografts in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1978)

Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.
por: Bernsen, H. J., et al.
Publicado: (1995)

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qj50hituoj9hc16shoqod48440